Entero Therapeutics (ENTO) got a $2 million revolving loan and appointed three new board members designated by the undisclosed lender as a condition for the funding.
Richard Paolone, Eric Corbett and Manpreet Uppal replaced James Sapirstein, Alastair Riddell and Timothy Ramdeen on the board, the company said Friday in a statement.
The board has five members. Sapirstein is chief executive officer of Entero.
Price: 0.55, Change: +0.03, Percent Change: +6.54